{
    "clinical_study": {
        "@rank": "102647", 
        "acronym": "GT", 
        "arm_group": [
            {
                "arm_group_label": "4 daily placebo tea bags for 12 weeks", 
                "arm_group_type": "Placebo Comparator", 
                "description": "All subjects will undergo a 12 weeks supplemented with four daily placebo maltodextrin \"tea-bags\". The subjects will be instructed than to brew the placebo sachets for five minute in 240 mL boiling water without stirring and to drink 4 cups per day for 12 weeks period (Placebo period)."
            }, 
            {
                "arm_group_label": "Four green tea bags per day for 12 weeks", 
                "arm_group_type": "Experimental", 
                "description": "After the placebo period, all subjects will undergo a 12 weeks supplemented with four daily green tea bags. The subjects will be instructed than to brew the green tea sachets for five minute in 240 mL boiling water without stirring and to drink 4 cups per day for 12 weeks period (Green tea period)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the beneficial effects of a long term (12 weeks)\n      green tea drinking on plasma, erythrocytes and saliva oxidative stress biomarkers and\n      antioxidant capacity, as well as on cardiometabolic risk factors: anthropometric,\n      inflammation and metabolic parameters in a healthy aging men and women."
        }, 
        "brief_title": "Green Tea Effect on Anthropometric, Oxidation and Inflammation Parameters in Physically Active vs. Sedentary Elders", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Aging", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "detailed_description": {
            "textblock": "A prospective, crossover trial in which every individual served its own control. All\n      subjects undergo a four weeks washout period, during which they briefed to avoid tea\n      drinking and antioxidant supplements until the end of the study. At the end of the washout\n      period, blood and saliva samples is collected after 12 hours of night fast. Subsequently,\n      all subjects receive the maltodextrin containing placebo \"tea bags\". The subjects instructed\n      to brew the placebo sachets for five minute in 240 mL boiling water without stirring and to\n      drink 4 cups per day for 12 weeks period (placebo period). After the placebo period, fasting\n      samples collected once more and the subjects receive the green tea bags. Preparation and\n      drinking instructions are the same as the placebo drink. At the end of the 12 weeks, green\n      tea drinking, fasting blood and saliva samples drawn for the third time. During the study,\n      every 4 weeks the subjects get additional placebo or green tea bags.  Assessment of\n      nutritional consumption of macronutrients and antioxidants using a food diary, physical\n      activity lifestyle as well as weight, body fat and circumference measurements is made at the\n      beginning, middle and end of the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy men and women\n\n          -  Age: 60-76 Years\n\n          -  Able to understand the meaning of Informed Consent procedure and willing to consent\n\n        Exclusion Criteria:\n\n          -  Any active disease state\n\n          -  Unstable chronic disease (diabetes, vascular, renal)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "76 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "43", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077660", 
            "org_study_id": "01", 
            "secondary_id": "Rambam MC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Four green tea bags per day for 12 weeks", 
                "description": "Four green tea bags per day for 12 weeks", 
                "intervention_name": "Four green tea bags per day for 12 weeks", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "4 daily placebo tea bags for 12 weeks", 
                "description": "4 daily placebo tea bags for 12 weeks", 
                "intervention_name": "4 daily placebo tea bags for 12 weeks", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Green tea, aging, oxidation, anthropometrics.", 
        "lastchanged_date": "March 11, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Rambam MC"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Green Tea on Anthropometric, Oxidation and Inflammation Parameters in Physically Active Elderly Compared to Sedentary Elderly", 
        "overall_official": {
            "affiliation": "Rambam Health Care Campus", 
            "last_name": "Yishai Levy, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Protein carbonyls, nmol/mg", 
                "measure": "Plasma protein carbonyls", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Thiobarbituric acid reactive substance , nmol/mL", 
                "measure": "Plasma thiobarbituric acid reactive substance", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Lipid peroxides, nmol/mL", 
                "measure": "Plasma lipid peroxides", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Catalase activity, milliunits/mg", 
                "measure": "Erythrocytes catalase", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "hemolysis test, percentage", 
                "measure": "Erythrocytes resistance to oxidative hemolysis", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Oral peroxidase activity, milliunits/mg", 
                "measure": "Saliva enzymatic antioxidants", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Total antioxidant capacity, millimolar/mg", 
                "measure": "Saliva antioxidant capacity", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077660"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Body weight, kg", 
                "measure": "Total body weight", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Body fat, %", 
                "measure": "Total body fat percentage", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Waist and hip circumference, cm", 
                "measure": "Body circumference", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Serum C-reactive protein mg/dL", 
                "measure": "Serum inflammatory status", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Saliva matrix metalloproteinase 8, \u00b5g/L", 
                "measure": "Saliva inflammatory status Saliva matrix metalloproteinase 8 (MMP8)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }, 
            {
                "description": "Saliva interleukin 8, ng/L", 
                "measure": "Saliva inflammatory status - saliva interleukin 8 (IL8)", 
                "safety_issue": "No", 
                "time_frame": "24 weeks"
            }
        ], 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}